e.g. Tata motors, Reliance MF, 500570

Infinium Pharmachem Ltd. - Research Center

Group () BSE data
 
Back to Company Page
Results:
Statement:

Profit loss account

(Rs crore)
Mar ' 24 Mar ' 23 Mar ' 22 Mar ' 21 Mar ' 20
Income
Operating income 122.36 101.31 74.04 54.56 36.04
Expenses
Material consumed 94.15 71.07 54.22 39.69 27.57
Manufacturing expenses 0.97 0.62 0.77 0.50 0.32
Personnel expenses 4.56 3.67 3.16 2.21 1.85
Selling expenses 0.50 0.33 0.17 0.17 0.20
Adminstrative expenses 4.77 10.41 7.00 7.08 3.46
Expenses capitalised - - - - -
Cost of sales 104.94 86.10 65.32 49.65 33.41
Operating profit 17.42 15.21 8.72 4.91 2.63
Other recurring income 1.63 1.34 0.93 0.62 0.57
Adjusted PBDIT 19.04 16.55 9.64 5.53 3.20
Financial expenses 1.78 3.00 1.66 1.12 1.23
Depreciation 2.41 1.29 0.58 0.65 0.58
Other write offs - - - - -
Adjusted PBT 14.86 12.26 7.41 3.76 1.39
Tax charges 3.77 3.12 1.90 1.04 0.37
Adjusted PAT 11.09 9.15 5.50 2.72 1.02
Non recurring items - - - - -
Other non cash adjustments - - - - -
Reported net profit 11.09 9.15 5.50 2.72 1.02
Earnigs before appropriation 27.71 19.92 10.77 5.26 2.53
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 27.71 19.92 10.77 5.26 2.53
Close
Add Infinium Pharmachem Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Infinium Pharmachem Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback